Endocrine tumors of the cervix: Morphologic assessment, expression of human papillomavirus, and evaluation for loss of heterozygosity on 1p, 3p, 11q, and 17p

Cancer

Volumn 83, Issue 7, 1998, Pages 1391-1400

  Mannion, Ciaran ^a   Park, Won Sang ^b   Man, Yan Gao ^a   Zhuang, Zhengping ^b   Albores Saavedra, Jorge ^c   Tavassoli, Fattaneh A ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

3p; Cervical carcinoma; Endocrine carcinoma; Human papillomavirus; In situ hybridization; Loss of heterozygosity; P53; Small cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CARCINOID; CHROMOSOME 11Q; CHROMOSOME 17P; CHROMOSOME 1P; CHROMOSOME 3P; CLINICAL ARTICLE; ENDOCRINE TUMOR; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LARGE CELL CARCINOMA; PRIORITY JOURNAL; SMALL CELL CARCINOMA; UTERINE CERVIX TUMOR; WART VIRUS;

EID: 0032190216     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19981001)83:7<1391::aid-cncr17>3.0.co;2-%23     Document Type: Article

References (78)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
2. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;46:5-27.
3. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997;47:10-11.
4. Reagan J, Mamonic MS, Wentz WB. Analytical study of the cells in cervical squamous cell cancer. Lab Invest 1957;6: 241-50.
5. Wentz WB, Reagan JW. Survival in cervical cancer with respect to cell type. Cancer 1959;12:384-8.
6. Ng ABP, Atkin NB. Histological cell type and DNA value in the prognosis of squamous cell carcinoma of the cervix. Br J Cancer 1973;28:322-31.
7. Swan DS, Roddick JW. A clinical-pathological correlation of cell type classification of cervical cancer. Am J Obstet Gynecol 1973;116:666-70.
8. van Nagell JR, Powell DE, Gallion HH, Elliott DG, Donaldson ES, Carpenter AE, et al. Small cell carcinoma of the uterine cervix. Cancer 1988;62:1586-93.
9. Abeler VM, Holm R, Nesland IM, Kjorstad KE. Small cell carcinoma of the cervix: a clinicopathologic study of 26 patients. Cancer 1994;73:627-37.
10. Sheridan E, Lorigan PC, Goepel J, Radstone DJ, Coleman RE. Small cell carcinoma of the cervix. Clin Oncol (R Coll Radiol) 1996;8:102-5.
11. Galanis E, Frytak S, Lloyd RV. Extrapulmonary small cell carcinoma. Cancer 1997;79:1729-36.
12. Albores-Saavedra J, Poucell S, Rodriguez-Martinez HA. Primary carcinoid of the cervix. Patologia 1972;10:185-93.
13. Albores-Saavedra J, Larraza-Hernandez O, Poucell S, Rodriguez-Martinez HA. Carcinoid of the uterine cervix: additional observations on a new tumor entity. Cancer 1976;38: 2328-42.
14. Albores-Saavedra J, Rodriguez-Martinez HA, Larraza-Hernandez O. Carcinoid tumors of the cervix. Pathol Annu 1979;14:273-91.
15. Daw E. Carcinoid tumor of the cervix. Postgrad Med J 1977; 53:272-3.
16. Warner TFCS. Carcinoid tumor of the uterine cervix. J Clin Pathol 1978;31:990-5.
17. Habib A, Kaneko M, Cohen CJ, Walker G. Carcinoid of the uterine cervix: a case report with light and electron microscopic studies. Cancer 1979;43:535-8.
18. Hariri J, Rasmussen EA, Hage E. Carcinoid tumor of the uterine cervix. Acta Obstet Gynecol Scand 1983;62:539-40.
19. Mullins JD, Hilliard GC. Cervical carcinoid ("agyrophil cell" carcinoma) associated with an endocervical adenocarcinoma: a light and ultrastructural study. Cancer 1981;47:785-90.
20. Stahl R, Demopoulos RI, Bigelow B. Carcinoid tumor within a squamous cell carcinoma of the cervix. Gynecol Oncol 1981;11:387-92.
21. Ulich TR, Liao SY, Layfield L, Romansky S, Cheng L, Lewin KJ. Endocrine and tumor differentiation markers in poorly differentiated small cell carcinoids of the cervix and vagina. Arch Pathol Lab Med 1986;110:1054-7.
22. Hsu C, Ma L, Wong LC, Chan CW. Non-endocrine carcinoid tumour of the uterine cervix: aspects of diagnosis and treatment. Br J Obstet Gynaecol 1981;88:1056-60.
23. Norris HJ, McCauley KM. Unusual forms of adenocarcinoma of the cervix: an update. Pathol Annu 1993;28 (Pt 1):73-95.
24. Hammar SP, Insalaco SJ, Lee RB, Bockus DE, Remington FL, Yu A. Amphicrine carcinoma of the cervix. Am J Clin Pathol 1992;97:516-22.
25. Tateishi R, Wada A, Hayakawa K, Hongo J, Ishii S. Argyrophil cell carcinomas (apudomas) of the uterine cervix: light and electron microscopic observations of 5 cases. Virchows Arch A Pathol Anat Histopathol 1975;366:257-74.
26. Matasuyama M, Inoue T, Ariyoshi Y, Doi M, Suchi T, Sato T, et al. Argyrophil cell carcinoma of the uterine cervix with ectopic production of ACTH, β-MSH, serotonin, histamine, and amylase. Cancer 1979;44:1813-23.
27. Stassart J, Crum CP, Yordan EL, Fenoglio CM, Richart RM. Argyrophilic carcinoma of the cervix: a report of a case with coexisting cervical intraepithelial neoplasia. Gynecol Oncol 1982;13:247-51.
28. Pazdur R, Bonomi P, Slayton R, Gould VE, Miller A, Jao W, et al. Neuroendocrine carcinoma of the cervix: implications for staging and therapy. Gynecol Oncol 1981;12:120-8.
29. Turner WA, Gallup DG, Talledo OE, Otken LB, Guthrie TH. Neuroendocrine carcinoma of the uterine cervix complicated by pregnancy: case report and review of the literature. Obstet Gynecol 1986;67:80S-83S.
30. Barrett RJ, Davos I, Leuchter RS, Lagasse LD. Neuroendocrine features in poorly differentiated and undifferentiated carcinomas of the cervix. Cancer 1987;60:2325-30.
31. Walker AN, Mills SE, Taylor PT. Cervical neuroendocrine carcinoma: a clinical and light microscopic study of 14 cases. Int J Gynecol Pathol 1988;7:64-74.
32. Gilks CB, Young RH, Gersell DJ, Clement PB. Large cell carcinoma of the uterine cervix: a clinicopathologic study of 12 cases. Am J Surg Pathol 1997;21(8):905-14.
33. Silva EG, Kott MM, Ordonez NG. Endocrine carcinoma intermediate cell type of the uterine cervix. Cancer 1984;54: 1705-13.
34. Jones HW, Plymate S, Gluck FB, Miles PA, Greene JF. Small cell nonkeratinizing carcinoma of the cervix associated with ACTH production. Cancer 1976;38:1629-35.
35. Van Nagell JR, Donaldson ES, Wood EG, Maruyama Y, Utley J. Small cell carcinoma of the cervix. Cancer 1977;40:2243-9.
36. Lojek MA, Fer MF, Kasselberg AG, Glick AD, Burnett LS, Julian CG, et al. Cushing's syndrome with small cell carcinoma of the uterine cervix. Am J Med 1980;69:140-4.
37. Miller B, Dockter M, Torky EL, Photopulos G. Small cell carcinoma of the cervix: a clinical and flow-cytometry study. Gynecol Oncol 1991;42:27-33.
38. Mackay B, Osborne BM, Wharton JT. Small cell tumor of the cervix with neuroepithelial features. Cancer 1979;43:1138-45.
39. Gersell DJ, Mazoujian G, Mutch DG, Rudloff MA. Small-cell undifferentiated carcinoma of the cervix. A clinicopathologic, ultrastructural, and immunocytochemical study of 15 cases. Am J Surg Pathol 1988;12:684-98.
40. Albores-Saavedra J, Gersell D, Gilks CB, Henson DE, Lindberg G, Santiago H, et al. Terminology of endocrine tumors of the cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute. Arch Pathol Lab Med 1997;121(1):34-9.
41. Gersell DJ. Small (oat) cell carcinoma of the cervix. Pathol Case Rev 1997;2(1):21-6.
42. Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GB Jr., Nieman L, et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma: an ultrastructural, immunohistochemical and flow cytometric study of 35 cases. Am J Surg Pathol 1991;15:529-53.
43. Whang-Peng J, Kao-Shan CS, Lee EC, Bunn PA, Carney DN, Gazdar AF. Specific chromosome defect associated with human small-cell lung cancer, deletion 3p(14-23). Science 1982;215:181-2.
44. Naylor SL, Johnson BE, Minna JD, Sakaguchi AY. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature 1987;329:451-4.
45. Yokota J, Wada M, Shimosata Y, Terada M, Sugimura T. Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc Natl Acad Sci USA 1987;84:9252-56.
46. Kok K, Osinga J, Carritt B, van der Hout AH, van der Veen AY, Landsvater RM, et al. Deletion of a DNA sequence of the chromosomal region 3p21 in all major types of lung cancer. Nature 1987;330:578-81.
47. Sameshima Y, Matsuno Y, Hirohashi S, Shimosato Y, Mizoguchi H, Sugimura T, et al. Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma. Oncogene 1992;7:451-7.
48. Petersen I, Langreck H, Wolf G, Schwendel A, Psille R, Vogt P, et al. Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br J Cancer 1997;75(1):79-86.
49. Yokota J, Tsukada Y, Nakajima T, Gottoh M, Shimosato Y, Mori N, et al. Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res 1989;49:3598-601.
50. Wistuba II, Montellano FD, Milchgrub S, Virmani AK, Behrens C, Chen H, et al. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res 1997;57:3154-8.
51. Crook T, Wrede D, Vousden KH. P53 point mutation in HPV-negative human cervical carcinoma cell lines. Oncogene 1991;6:873-5.
52. Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ, Vousden KH. Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours. Lancet 1992;339:1070-3.
53. Fujita K, Inoue M, Tanizawa O, Iwamoto S, Enomoto T. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res 1992;52:5323-8.
54. Helland Å, Holm R, Kaern J. TP53 mutation and HPV-infection in primary cervical carcinomas. In: Proceedings of the Third European Workshop on Cytogenetics and Molecular Genetics of Human Solid Tumours, Porto, Portugal, April 26-9, 1992.
55. Pao CC, Kao S-M, Chen JH, Tang GC, Chang PY, Tan TT. State of mutational alterations of p53 and retinoblastoma susceptibility genes in papillomavirus-negative small cell cervical carcinomas. J Surg Oncol 1994;57:87-93.
56. Zhuang Z, Berttheau P, Emmert-Buck M, Liotta LA, Gnarra J, Linehan WM, et al. A new microdissection technique for archival DNA analysis of specific cell populations in lesions less than one millimeter. Am J Pathol 1995;146:620-5.
57. Herrington CS, Burns J, Graham AK, Evans M, O'D McGee J. Interphase cytogenetics using biotin and digoxigenin labelled probes I: relative sensitivity of both reporter molecules for detection of HPV 16 in CaSki cells. J Clin Pathol 1989;42:592-600.
58. Herrington CS, Burns I, Graham AK, Bhatt B, O'D McGee J. Interphase cytogenetics using biotin and digoxigenin labelled probes II: simultaneous differential detection of human and papilloma virus nucleic acids in individual nuclei. J Clin Pathol 1989;42:601-6.
59. Herrington CS, Graham AK, O'D McGee J. Interphase cytogenetics using biotin and digoxigenin labelled probes III: increased sensitivity and flexibility for detecting HPV in cervical biopsy specimens and cell lines. J Clin Pathol 1991; 44:33-8.
60. Cooper K, Herrington CS, Strickland JE, Evans MF, O'D McGee J. Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridization. J Clin Pathol 1991;44:990-6.
61. Kristiansen E, Jenkins A, Holm R. Coexistence of episomal and integrated HPV 16 DMA in squamous cell carcinoma of the cervix. J Clin Pathol 1994;57:253-6.
62. Berumen J, Unger ER, Casas L, Figueroa P. Amplification of human papillomavirus types 16 and 18 in invasive cervical cancer. Hum Pathol 1995;26:676-81.
63. Stoler MH, Mills SE, Gersell DJ, Walker AN, Small-cell neuroendocrine carcinoma of the cervix. A human papillomavirus Type 18-associated cancer. Am J Surg Pathol 1991;15:28-32.
64. Hibi K, Takahashi T, Yamakawa K, Ueda R, Sekido Y, Ariyashi Y, et al. Three distinct regions involved in 3p deletion in human lung cancer. Oncogene 1992;7:445-9.
65. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue H, et al. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 1996;85:17-26.
66. Sozzi G, Miozzo M, Tagliabue E, Calderone C, Lombardi L, Pilotti S. Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients. Cancer Res 1991;51:400-4.
67. Zbar B, Braugh H, Talmadge C, Linehan M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature 1987;327:721-4.
68. Kovacs G, Erlandsson R, Boldog F, Ingvarsson S, Muller-Brechlin R, Klein G, et al. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci USA 1988;85:1571-5.
69. Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehen NM, et al. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumors, are detectable in preinvasive lesions of the bronchus. Oncogene 1992;7:1989-97.
70. Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire DD, Minna JD, et al. Allele specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 1995;273:558-63.
71. Pao CC, Lin C-Y, Chang Y-L, Tseng CJ, Hsueh S. Human papillomaviruses and small cell carcinoma of the uterine cervix. Gynecol Oncol 1991;43:206-10.
72. Kessis TD, Slebos RJ, Han SM, Shah K, Bosch XF, Munoz N, et al. p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix. Am J Pathol 1994;143:1398-405.
73. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63:1129-36.
74. Crook T, Tidy JA, Vousden KH. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 1991;67: 547-56.
75. Scheffner M, Munger K, Byrne JC, Howley PM. The state of p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 1991;88:5523-7.
76. Stoler MH. The biology of human papillomaviruses. Pathol Case Rev 1997;2(1):8-20.
77. Durst M, Croce CM, Gissmann L, Schwarz E, Huebner K. Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci USA 1987; 84:1070-4.
78. Cannizzaro LA, Durst M, Huebner K, Croce C, Hecht BK, Hecht F. Chromosome sublocalization of cervical carcinoma papillomavirus sites near cellular protooncogenes and fragile sites. Cytogenet Cell Genet 1987;46:590.